Roka Bioscience Wraps Up Initial Public Offering on NASDAQ
Roka Bioscience, Inc., a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, on July 17 announced its initial public offering of five million shares of its common stock at $12 per share, before underwriting discounts. All of the common stock was offered by Roka Bioscience.
Roka Bioscience also has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price. The shares began trading on the NASDAQ Global Market on July 17 under the ticker symbol "ROKA," and the offering was slated to close yesterday.